Neurocysticercosis and epilepsy: Imaging and clinical characteristics.
CT
MRI
epilepsy
neurocysticercosis
neuroimaging
Journal
Epileptic disorders : international epilepsy journal with videotape
ISSN: 1950-6945
Titre abrégé: Epileptic Disord
Pays: United States
ID NLM: 100891853
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
revised:
24
03
2023
received:
09
01
2023
accepted:
05
04
2023
medline:
23
5
2023
pubmed:
12
4
2023
entrez:
11
4
2023
Statut:
ppublish
Résumé
The ILAE Neuroimaging Task Force aimed to publish educational case reports highlighting basic aspects related to neuroimaging in epilepsy consistent with the educational mission of the ILAE. Neurocysticercosis (NCC) is highly endemic in resource-limited countries and increasingly more often seen in non-endemic regions due to migration. Cysts with larva of the tapeworm Taenia solium lodge in the brain and cause several neurological conditions, of which seizures are the most common. There is great heterogeneity in the clinical presentation of neurocysticercosis because cysts vary in number, larval stage, and location among patients. We here present two illustrative cases with different clinical features to highlight the varying severity of symptoms secondary to this parasitic infestation. We also present several examples of imaging characteristics of the disease at various stages, which emphasize the central role of neuroimaging in the diagnosis of neurocysticercosis.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
94-103Informations de copyright
© 2023 The Authors. Epileptic Disorders published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
Références
Kimura-Hayama ET, Higuera JA, Corona-Cedillo R, Chávez-Macías L, Perochena A, Quiroz-Rojas LY, et al. Neurocysticercosis: radiologic-pathologic correlation. Radiographics. 2010;30:1705-19. https://doi.org/10.1148/rg.306105522
Garcia HH. Neurocysticercosis. Neurol Clin. 2018;36:851-64. https://doi.org/10.1016/j.ncl.2018.07.003
Mazumder R, Lee JK. Epileptogenesis in common parasitic infections. Curr Neurol Neurosci Rep. 2022;22:285-91. https://doi.org/10.1007/s11910-022-01187-6
Del Brutto OH. Neurocisticercosis: actualización en diagnóstico y tratamiento. Neurologia (Barc ed Impr). 2005;412-8.
Giménez-Roldán S, Díaz F, Esquivel A. Neurocisticercosis e inmigración. Neurologia. 2003;18:385-8.
Bern C, Garcia HH, Evans C, Gonzalez AE, Verastegui M, Tsang VC, et al. Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis off Publ Infect Dis Soc Am. 1999;29:1203-9. https://doi.org/10.1086/313470
Garcia HH, Gonzalez AE, Tsang VCW, Gilman RH. Neurocysticercosis: some of the essentials. Pract Neurol. 2006;6:288-97. https://doi.org/10.1136/jnnp.2006.101253
Carabin H, Ndimubanzi PC, Budke CM, Nguyen H, Qian Y, Cowan LD, et al. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis. 2011;5:e1152. https://doi.org/10.1371/journal.pntd.0001152
García HH, Gonzalez AE, Evans CAW, Gilman RH. Cysticercosis working Group in Peru. Taenia Solium Cysticercosis Lancet Lond Engl. 2003;362:547-56. https://doi.org/10.1016/S0140-6736(03)14117-7
Garcia HH, Nash TE, Del Brutto OH. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol. 2014;13:1202-15. https://doi.org/10.1016/S1474-4422(14)70094-8
Del Brutto OH. Neurocysticercosis. Handb Clin Neurol. 2014;121:1445-59. https://doi.org/10.1016/B978-0-7020-4088-7.00097-3
Flisser A. Taeniasis and cysticercosis due to taenia solium. Prog Clin Parasitol. 1994;4:77-116.
Lescano AG, Garcia HH, Gilman RH, Gavidia CM, Tsang VCW, Rodriguez S, et al. Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures. PLoS Negl Trop Dis. 2009;3:e371. https://doi.org/10.1371/journal.pntd.0000371
O'Neal SE, Moyano LM, Ayvar V, Gonzalvez G, Diaz A, Rodriguez S, et al. Geographic correlation between tapeworm carriers and heavily infected cysticercotic pigs. PLoS Negl Trop Dis. 2012;6:e1953. https://doi.org/10.1371/journal.pntd.0001953
Guzman C, Garcia HH. Current diagnostic criteria for neurocysticercosis. Res Rep Trop Med. 2021;12:197-203. https://doi.org/10.2147/RRTM.S285393
Garcia HH, Del Brutto OH, Cysticercosis Working Group in Peru. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol. 2005;4:653-61. https://doi.org/10.1016/S1474-4422(05)70194-0
Takayanagui OM, Odashima NS. Clinical aspects of neurocysticercosis. Parasitol Int. 2006;55:S111-5. https://doi.org/10.1016/j.parint.2005.11.016
Nash TE, Garcia HH. Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol. 2011;7:584-94. https://doi.org/10.1038/nrneurol.2011.135
Vezzani A, Fujinami RS, White HS, Preux P-M, Blümcke I, Sander JW, et al. Infections, inflammation and epilepsy. Acta Neuropathol (Berl). 2016;131:211-34. https://doi.org/10.1007/s00401-015-1481-5
Del Brutto OR, Rajshekhar V, White AC, Tsang VCW, Nash TE, Takayanagui OM, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology. 2001;57:177-83.
Carpio A, Fleury A, Romo ML, Abraham R, Fandiño J, Durán JC, et al. New diagnostic criteria for neurocysticercosis: reliability and validity. Ann Neurol. 2016;80:434-42. https://doi.org/10.1002/ana.24732
Del Brutto OH, Santibañez R, Noboa CA, Aguirre R, Díaz E, Alarcón TA. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology. 1992;42:389-9. https://doi.org/10.1212/WNL.42.2.389
Kelvin EA, Carpio A, Bagiella E, Leslie D, Leon P, Andrews H, et al. Seizure in people with newly diagnosed active or transitional neurocysticercosis. Seizure. 2011;20:119-25. https://doi.org/10.1016/j.seizure.2010.10.036
DeGiorgio CM, Medina MT, Durón R, Zee C, Escueta SP. Neurocysticercosis. Epilepsy Curr. 2004;4:107-11. https://doi.org/10.1111/j.1535-7597.2004.43008.x
Duque KR, Burneo JG. Clinical presentation of neurocysticercosis-related epilepsy. Epilepsy Behav EB. 2017;76:151-7. https://doi.org/10.1016/j.yebeh.2017.08.008
Kobayashi E, Guerreiro CA, Cendes F. Late onset temporal lobe epilepsy with MRI evidence of mesial temporal sclerosis following acute neurocysticercosis: case report. Arq Neuropsiquiatr. 2001;59:255-8. https://doi.org/10.1590/s0004-282x2001000200021
Gripper LB, Welburn SC. Neurocysticercosis infection and disease-a review. Acta Trop. 20w17;166:218-24. https://doi.org/10.1016/j.actatropica.2016.11.015
Baird RA, Wiebe S, Zunt JR, Halperin JJ, Gronseth G, Roos KL. Evidence-based guideline: treatment of parenchymal neurocysticercosis. Neurology. 2013;80:1424-9. https://doi.org/10.1212/WNL.0b013e31828c2f3e
Mejia R, Nash TE. Corticosteroid withdrawal precipitates perilesional edema around calcified taenia solium cysts. Am J Trop Med Hyg. 2013;89:919-23. https://doi.org/10.4269/ajtmh.13-0350
Mitre E, Talaat KR, Sperling MR, Nash TE. Methotrexate as a corticosteroid-sparing agent in complicated neurocysticercosis. Clin Infect Dis. 2007;44:549-53. https://doi.org/10.1086/511040
White AC Jr, Coyle CM, Rajshekhar V, Singh G, Hauser WA, Mohanty A, et al. Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2018;66:e49-75. https://doi.org/10.1093/cid/cix1084
Espino PH, Couper RG, Burneo JG. An update on neurocysticercosis-related epilepsy. Clin Neurol Neurosurg. 2022;213:107139. https://doi.org/10.1016/j.clineuro.2022.107139
Velasco TR, Zanello PA, Dalmagro CL, Araújo D, Santos AC, Bianchin MM, et al. Calcified cysticercotic lesions and intractable epilepsy: a cross sectional study of 512 patients. J Neurol Neurosurg Psychiatry. 2006;77:485-8. https://doi.org/10.1136/jnnp.2005.078675
da Gama CN, Kobayashi E, Li LM, Cendes F. Hippocampal atrophy and neurocysticercosis calcifications. Seizure. 2005;14:85-8. https://doi.org/10.1016/j.seizure.2004.10.005
Singh G, Chowdhary AK. Epilepsy surgery in context of neurocysticercosis. Ann Indian Acad Neurol. 2014;17:S65-8. https://doi.org/10.4103/0972-2327.128660
Escalaya AL, Burneo JG. Epilepsy surgery and neurocysticercosis: assessing the role of the cysticercotic lesion in medically-refractory epilepsy. Epilepsy Behav EB. 2017;76:178-81. https://doi.org/10.1016/j.yebeh.2017.01.029
Giussani C, Guida L, Trezza A, Sganzerla EP. Effectiveness of intraventricular endoscopic lamina terminalis fenestration in comparison with standard ETV: systematic review of literature. World Neurosurg. 2017;103:257-64. https://doi.org/10.1016/j.wneu.2017.03.143
Del Brutto OH, Nash TE, White AC, Rajshekhar V, Wilkins PP, Singh G, et al. Revised diagnostic criteria for neurocysticercosis. J Neurol Sci. 2017;372:202-10. https://doi.org/10.1016/j.jns.2016.11.045
Bernasconi A, Cendes F, Theodore WH, Gill RS, Koepp MJ, Hogan RE, et al. Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: a consensus report from the international league against epilepsy neuroimaging task force. Epilepsia. 2019;60:1054-68. https://doi.org/10.1111/epi.15612
Wang I, Bernasconi A, Bernhardt B, Blumenfeld H, Cendes F, Chinvarun Y, et al. MRI essentials in epileptology: a review from the ILAE imaging taskforce. Epileptic Disord Int Epilepsy J Videotape. 2020;22:421-37. https://doi.org/10.1684/epd.2020.1174
Bickerstaff ER, Cloake PCP, Hughes B, Smith WT. The racemose form of cerebral cysticercosis. Brain J Neurol. 1952;75:1-18. https://doi.org/10.1093/brain/75.1.1
Garcia HH, Gonzales I, Lescano AG, Bustos JA, Zimic M, Escalante D, et al. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Lancet Infect Dis. 2014;14:687-95. https://doi.org/10.1016/S1473-3099(14)70779-0
Michelet L, Fleury A, Sciutto E, Kendjo E, Fragoso G, Paris L, et al. Human neurocysticercosis: comparison of different diagnostic tests using cerebrospinal fluid. J Clin Microbiol. 2011;49:195-200. https://doi.org/10.1128/JCM.01554-10
Hernández M, Astudillo O-G, Diego G, de-la-Rosa-Arana J-L, Meza-Lucas A, García-Rodea R, et al. Immunodiagnosis of human neurocysticercosis: comparative performance of serum diagnostic tests in Mexico. Parasitol Res. 2019;118:2891-9. https://doi.org/10.1007/s00436-019-06425-4
Nash TE, Pretell EJ, Lescano AG, Bustos JA, Gilman RH, Gonzalez AE, et al. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol. 2008;7:1099-105. https://doi.org/10.1016/S1474-4422(08)70243-6
Jama-António JMC, Yasuda CL, Cendes F. Intermittent perilesional edema and contrast enhancement in epilepsy with calcified neurocysticercosis may help to identify the seizure focus. Epilepsia Open. 2019;4:351-4. https://doi.org/10.1002/epi4.12324
Yacubian EMT, Kakooza-Mwesige A, Singh G, Carpio A, de Figueiredo NV, Lutzky Saute R, et al. Common infectious and parasitic diseases as a cause of seizures: geographic distribution and contribution to the burden of epilepsy. Epileptic Disord Int Epilepsy J Videotape. 2022;24:994-1019. https://doi.org/10.1684/epd.2022.1491